Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BMY
BMY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BMY News
Bristol Myers Squibb Shares Rebound but Risks Remain
6d ago
Fool
Bristol Myers Squibb Faces Daunting Patent Cliff
6d ago
NASDAQ.COM
BMY Shares Snap Six-Day Gain with Minor Decline
May 22 2026
seekingalpha
Bristol Myers Squibb Showcases New Drug Research Results
May 21 2026
Newsfilter
Bristol Myers Squibb's Stock Lacks Confidence Despite Strong Fundamentals
May 21 2026
Fool
Bristol Myers Squibb Valuation Low but Growth Prospects Positive
May 21 2026
NASDAQ.COM
BioArctic AB Reports Strong Earnings, Positive Outlook for Leqembi Sales
May 20 2026
Yahoo Finance
Bloomsbury Publishing Reports 7% Profit Increase and Dividend Boost
May 20 2026
Yahoo Finance
Bristol Myers Squibb Partners with Anthropic to Deploy Claude AI
May 20 2026
Newsfilter
Bristol-Myers Squibb Expands AI Applications with Anthropic's Claude Platform
May 20 2026
seekingalpha
Three High-Yield Safe Stocks to Consider
May 18 2026
Fool
US Supreme Court Rejects Pharma Challenge to Medicare Drug Price Negotiation Plan
May 18 2026
Newsfilter
Johnson & Johnson's Icotyde Shows Strong Potential as a Cash Cow
May 16 2026
CNBC
Regeneron's Fianlimab Trial Fails to Meet Key Goals
May 16 2026
stocktwits
Bristol Myers Squibb Partners with Hengrui Pharma for Drug Development
May 15 2026
CNBC
Bristol Myers Squibb Partners with Hengrui Pharma for Drug Development
May 15 2026
Newsfilter
Show More News
